Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | KIF11 | P52732 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | ATP2A2 | P16615 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | ATP2A3 | Q93084 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2906636 | 0.78 | CA2 (0.35) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL304569 | 0.77 | CA2 (0.57) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL17984171 | 0.75 | ALDH1A1 (0.56) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL11961295 | 0.73 | CA2 (0.36) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL8357982 | 0.73 | CA2 (0.41) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL29143058 | 0.72 | CA2 (0.43) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL2679447 | 0.72 | CA2 (0.39) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL144221 | 0.71 | ALDH1A1 (0.62) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL29395629 | 0.71 | ALDH1A1 (0.62) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL9065190 | 0.71 | CA2 (0.42) | CA2GABRA1GABRB2ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 634 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2212892-A1 | SEMICONDUCTIVE POLYMER COMPOSITION | Borealis Technology OY (FI) | 2010-08-04 | — | — | EP | claimed |
| WO-2009053042-A1 | SEMICONDUCTIVE POLYMER COMPOSITION | BOREALIS TECHNOLOGY OY (FI) | 2009-04-30 | — | — | WO | claimed |
| EP-0001149-B1 | PROCESS FOR THE PREPARATION OF 3-BROMOMETHYL-3-CEPHEM-SULPHOXIDE DERIVATIVES | GIST-BROCADES N.V. (NL) | 1981-06-03 | — | — | EP | claimed |
| EP-4711410-A1 | COMPOSITION WITH BALANCE OF DISSIPATION FACTOR AND ADDITIVE ACCEPTANCE | Dow Global Technologies LLC (US) | 2026-03-18 | — | — | EP | disclosed |
| US-20260055263-A1 | FLAME RETARDANT POLYMERIC COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-02-26 | — | — | US | disclosed |
| WO-2026043539-A1 | POLYMERIC COMPOSITION INCLUDING POLYALKYLENE GLYCOL | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-02-26 | — | — | WO | disclosed |
| EP-3728443-B1 | CABLE MADE FROM CROSSLINKABLE COMPOSITION WITH ANTIOXIDANT AND BENEFICIAL METHANE FORMATION | BOREALIS GMBH (AT) | 2026-02-04 | — | — | EP | disclosed |
| US-20260027750-A1 | Continuous Extruder Process for Manufacturing Rheology-Modified Polyolefin for Cable Insulation Layer, and Related Products | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-01-29 | — | — | US | disclosed |
| US-12516185-B2 | Polymeric compositions | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-01-06 | — | — | US | disclosed |
| EP-3541869-B1 | COMPOSITION WITH BALANCE OF DISSIPATION FACTOR AND ADDITIVE ACCEPTANCE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-11-05 | — | — | EP | disclosed |
| EP-3541874-B1 | COMPOSITION WITH BALANCE OF DISSIPATION FACTOR AND ADDITIVE ACCEPTANCE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-11-05 | — | — | EP | disclosed |
| EP-0375828-A2 | Cable conductor shield | UNION CARBIDE CORPORATION (US) | 1990-07-04 | — | — | EP | disclosed |
| EP-0374596-A2 | Cable coated with a flame retardant composition | UNION CARBIDE CHEMICALS AND PLASTICS COMPANY, INC. (US) | 1990-06-27 | — | — | EP | disclosed |
| EP-0372540-A2 | Flame retardant compositions | UNION CARBIDE CHEMICALS AND PLASTICS COMPANY, INC. (US) | 1990-06-13 | — | — | EP | disclosed |
| EP-0370518-A2 | Flame retardant composition | NIPPON UNICAR COMPANY LIMITED (JP) | 1990-05-30 | — | — | EP | disclosed |
| EP-0369473-A2 | Flame retardant compositions | UNION CARBIDE CHEMICALS AND PLASTICS COMPANY, INC. (US) | 1990-05-23 | — | — | EP | disclosed |
| US-4913965-A | BLEND OF ETHYLENE-VINYL ACETATE COPOLYMER AND MAGNESIUM HYDROXIDE | UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (US) | 1990-04-03 | — | — | US | disclosed |
| EP-0352699-A1 | Flame retardant composition | NIPPON UNICAR COMPANY LIMITED (JP) | 1990-01-31 | — | — | EP | disclosed |
| US-4734440-A | POLYETHYLENE OR ETHYL ACRYLATE-ETHYLENE COPOLYMER MODIFIED BY UNSATURATED SILANE | UNION CARBIDE CORPORATION (US) | 1988-03-29 | — | — | US | disclosed |
| US-4182870-A | BROMINATION, DEBROMINATION | GIST-BROCADES N.V. (NL) | 1980-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260027750-A1 | Continuous Extruder Process for Manufacturing Rheology-Modified Polyolefin for Cable Insulation Layer, and Related Products | SEC16A, RBM17, IDE | CA2 4668/4885GABRA1 2254/4885GABRB2 2060/4885 |
| US-20260055263-A1 | FLAME RETARDANT POLYMERIC COMPOSITIONS | GRM1, ERCC1, GRM2 | CA2 685/4885GABRA1 1125/4885GABRB2 1672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.